SOUTH PLAINFIELD, N.J. (AP) — PTC Therapeutics Inc. raised more than $125 million after the drug developer priced an initial public offering of its stock near the top end of the range it expected.
The South Plainfield, N.J., company said it expects proceeds of about $114.2 million after deducting underwriting discounts and commissions.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.